P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.

Detalles Bibliográficos
Autores principales: Maximova, Natalia, Nistico’, Daniela, Marcuzzi, Annalisa, Rimondi, Erika, Tessitore, Antimo, Riccio, Guglielmo, Barbi, Egidio, Paolo, Antonello DI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430541/
http://dx.doi.org/10.1097/01.HS9.0000972068.73278.65
_version_ 1785090988908216320
author Maximova, Natalia
Nistico’, Daniela
Marcuzzi, Annalisa
Rimondi, Erika
Tessitore, Antimo
Riccio, Guglielmo
Barbi, Egidio
Paolo, Antonello DI
author_facet Maximova, Natalia
Nistico’, Daniela
Marcuzzi, Annalisa
Rimondi, Erika
Tessitore, Antimo
Riccio, Guglielmo
Barbi, Egidio
Paolo, Antonello DI
author_sort Maximova, Natalia
collection PubMed
description
format Online
Article
Text
id pubmed-10430541
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305412023-08-17 P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY. Maximova, Natalia Nistico’, Daniela Marcuzzi, Annalisa Rimondi, Erika Tessitore, Antimo Riccio, Guglielmo Barbi, Egidio Paolo, Antonello DI Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430541/ http://dx.doi.org/10.1097/01.HS9.0000972068.73278.65 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Maximova, Natalia
Nistico’, Daniela
Marcuzzi, Annalisa
Rimondi, Erika
Tessitore, Antimo
Riccio, Guglielmo
Barbi, Egidio
Paolo, Antonello DI
P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.
title P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.
title_full P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.
title_fullStr P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.
title_full_unstemmed P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.
title_short P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.
title_sort p1295: advantage of first-line tdm-driven use of infliximab for treating acute intestinal and liver gvhd in children: a prospective, single-center study.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430541/
http://dx.doi.org/10.1097/01.HS9.0000972068.73278.65
work_keys_str_mv AT maximovanatalia p1295advantageoffirstlinetdmdrivenuseofinfliximabfortreatingacuteintestinalandlivergvhdinchildrenaprospectivesinglecenterstudy
AT nisticodaniela p1295advantageoffirstlinetdmdrivenuseofinfliximabfortreatingacuteintestinalandlivergvhdinchildrenaprospectivesinglecenterstudy
AT marcuzziannalisa p1295advantageoffirstlinetdmdrivenuseofinfliximabfortreatingacuteintestinalandlivergvhdinchildrenaprospectivesinglecenterstudy
AT rimondierika p1295advantageoffirstlinetdmdrivenuseofinfliximabfortreatingacuteintestinalandlivergvhdinchildrenaprospectivesinglecenterstudy
AT tessitoreantimo p1295advantageoffirstlinetdmdrivenuseofinfliximabfortreatingacuteintestinalandlivergvhdinchildrenaprospectivesinglecenterstudy
AT riccioguglielmo p1295advantageoffirstlinetdmdrivenuseofinfliximabfortreatingacuteintestinalandlivergvhdinchildrenaprospectivesinglecenterstudy
AT barbiegidio p1295advantageoffirstlinetdmdrivenuseofinfliximabfortreatingacuteintestinalandlivergvhdinchildrenaprospectivesinglecenterstudy
AT paoloantonellodi p1295advantageoffirstlinetdmdrivenuseofinfliximabfortreatingacuteintestinalandlivergvhdinchildrenaprospectivesinglecenterstudy

Ejemplares similares